Skip to main content

Explosion in Genetic Knowledge Creates New Global Market for Genetic Testing - A Complex Market With Unlimited Potential -

The "Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides 2023 to 2027" report has been added to's offering.

Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry.

The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

This research makes you the expert in your organization. Make investment decisions and valuations with confidence using the latest data.

Key Topics Covered:

1 Market Guides

1.1 Genetic Testing - Strategic Situation Analysis & Company Rankings

1.2 Guide for Executives, Marketing, Sales and Business Development Staff

1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

2.1 Genetic Testing Definition in This Report

2.2 The Genomics Revolution

2.3 Market Definition

2.3.1 Revenue Market Size

2.3.2 Newborn Screening

2.3.3 Non Invasive Pregnancy Testing

2.3.4 Predictive

2.3.5 Oncology

2.3.6 Direct to Consumer

2.3.7 Other Application

2.3.8 PCR

2.3.9 NGS

2.3.10 Cytogenetic

2.3.11 Other Technology

2.4 Methodology

2.5 Perspective: Healthcare and the IVD Industry

2.6 Chromosomes, Genes and Epigenetics

2.6.1 Chromosomes

2.6.2 Genes

2.6.3 Epigenetics

3 Market Overview

3.1 Players in a Dynamic Market

3.1.1 Academic Research Lab

3.1.2 Diagnostic Test Developer

3.1.3 Instrumentation Supplier

3.1.4 Chemical/Reagent Supplier

3.1.5 Pathology Supplier

3.1.6 Independent Clinical Laboratory

3.1.7 Public National/regional Laboratory

3.1.8 Hospital Laboratory

3.1.9 Physicians Office Lab (POLS)

3.1.10 Audit Body

3.1.11 Certification Body

3.2 Genetic Tests - Types, Examples and Discussion

3.2.1 Preimplantation Genetic Diagnosis - An Emerging Market

3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity

3.2.3 Newborn Screening

3.2.4 Diagnostic Testing

3.2.5 Carrier Testing

3.2.6 Predictive and Presymptomatic Testing

3.2.7 Pharmacogenomics

3.2.8 Forensic Testing

3.2.9 Parental Testing

3.2.10 Ancestral Testing

3.3 Industry Structure

3.3.1 Hospital's Testing Share

3.3.2 Economies of Scale

3.3.3 Hospital vs. Central Lab

3.3.4 Physician Office Lab's

3.3.5 Physician's and POCT

4 Market Trends

4.1 Factors Driving Growth

4.1.1 Genetic Discoveries Creating New Diagnostic Markets

4.1.2 The Aging Effect

4.1.3 Pharmacogenomics Drives Further Growth

4.1.4 Oncology and Liquid Biopsy Enter New Era

4.1.5 Fertility Practice Growth drives market

4.1.6 Direct to Consumer begins to break out

4.2 Factors Limiting Growth

4.2.1 Increased Competition Lowers Price

4.2.2 Lower Costs

4.2.3 Testing usage analysis curtailing growth

4.2.4 Wellness has a downside

4.3 Instrumentation, Automation and Diagnostic Trends

4.3.1 Traditional Automation and Centralization

4.3.2 The New Automation, Decentralization and Point of Care

4.3.3 Instruments Key to Market Share

4.3.4 Bioinformatics Plays a Role

4.3.5 PCR Takes Command

4.3.6 Next Generation Sequencing Fuels a Revolution

4.3.7 NGS Impact on Pricing

4.3.8 Whole Genome Sequencing, A Brave New World

4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment

4.3.10 Shifting Role of Diagnostics

5 Genetic Testing Recent Developments

  • Novitas Rescinds Coverage for Multiple Genetic Tests
  • PerkinElmer (now Revvity) Becomes Dx Life Science Firm
  • New POC Genotyping Tests Based on Electromagnetic Detection
  • GenoMe Dx Launching dPCR Cancer Test
  • mDetect To Trial Breast Cancer Liquid Biopsy
  • Genomics England, Aims to Sequence 100K Newborns
  • Juno Diagnostics NIPT With At-Home Sample Collection
  • Cardio Diagnostics Launches Genetic Cario Risk Test
  • Universal Genetic Testing in Breast Cancer Further Supported
  • Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
  • MyOme Lands Investment for WGS
  • Type 2 Diabetes GWAS Enables Risk Prediction
  • LetsGetChecked to Acquire Veritas Genetics
  • Guardant Health Plans New Comprehensive Assay
  • Tesis Labs Raises $20M
  • Sema4: Sema4 Elements
  • Clarified Precision Medicine Acquires Interpares Biomedicine
  • Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
  • NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
  • Progenity Revenues Fall on COVID-19 Effect
  • Natera Launches Tumor Genomic Profiling Assay
  • 23andMe To Go Public
  • Guardant Health to Offer Tumor Tissue Sequencing
  • Ancestry Quits Health Offering
  • DTC Firm MyDNA Merges With Gene by Gene
  • Aetna Coverage for NIPT to Include All Pregnancies
  • Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
  • Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

6 Profiles of Key Companies

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agilent/Dako
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd.
  • LLC
  • Anchor Dx
  • Arc Bio
  • Arrayit Corporation
  • ARUP Laboratories
  • Aus Diagnostics
  • BaseClear
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • C2i Genomics
  • CareDx
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Cepheid (Danaher)
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • CosmosID
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • Element Biosciences
  • Element Biosciences
  • Epic Sciences
  • Epigenomics AG.
  • Eurofins Scientific
  • Excellerate Bioscience
  • Fabric Genomics
  • Freenome
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneFirst Ltd.
  • Genetron Holdings
  • Genomics England
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helix OpCo
  • Helomics
  • Hologic
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Letsgetchecked
  • Lunglife AI Inc
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Menarini Silicon Biosystems
  • Meridian Bioscience
  • Mesa Biotech (Thermo Fisher)
  • Mesa Laboratories, Inc.
  • Metabiomics Corp
  • miR Scientific
  • MNG Labs
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New England Biolabs, Inc.
  • NGeneBio
  • Novogene Bioinformatics Technology Co., Ltd.
  • Omega Bioservices
  • Oncocyte
  • OncoDNA
  • OpGen
  • ORIG3N, Inc.
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • PathoQuest S.A.
  • Perkin Elmer (now Revvity)
  • Personal Genome Diagnostics
  • Personalis.
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen
  • QuantuMDx
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sema4 Holdings
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singular Genomics
  • SkylineDx
  • Standard BioTools
  • Sure Genomics, Inc.
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics
  • Ultima Genomics
  • Variantyx
  • Vela Diagnostics
  • Volition
  • Vyant Bio
  • Zymo Research Corp

7 Global Market Size

8 Market Sizes by Application

9 Global Genetic Testing Market by Technology

10 Global Genetic Testing Market by Product

11 Global Genetic Testing Market by User

12 The Future of Genetic Testing

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.